Insulin aspart, recombinant Subcutaneous and Pyridostigmine ER tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pyridostigmine ER tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pyridostigmine
Brand name: Mestinon, Mestinon Timespan, Regonol
Synonyms: Pyridostigmine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pyridostigmine Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Pyridostigmine Injection
- Insulin aspart, recombinant Subcutaneous-Pyridostigmine Liquid
- Insulin aspart, recombinant Subcutaneous-Pyridostigmine Oral Solution
- Insulin aspart, recombinant Subcutaneous-Pyridostigmine Tablets
- Insulin aspart, recombinant Subcutaneous-Pyridoxine
- Pyridostigmine ER tablets-Insulin degludec
- Pyridostigmine ER tablets-Insulin Degludec (U-100) Prefilled Pens
- Pyridostigmine ER tablets-Insulin Degludec (U-100) Vials
- Pyridostigmine ER tablets-Insulin Degludec (U-200) Prefilled Pens
- Pyridostigmine ER tablets-Insulin degludec and liraglutide
- Pyridostigmine ER tablets-Insulin degludec and liraglutide Subcutaneous